Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
5(26%)
Results Posted
33%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
4
21%
Ph phase_2
5
26%

Phase Distribution

0

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
5(55.6%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

5

trials recruiting

Total Trials

19

all time

Status Distribution
Active(5)
Completed(9)
Terminated(2)
Other(3)

Detailed Status

Completed9
unknown3
Active, not recruiting3
Recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
5
Success Rate
90.0%
Most Advanced
Phase 2

Trials by Phase

Phase 25 (55.6%)
N/A4 (44.4%)

Trials by Status

completed947%
recruiting211%
unknown316%
terminated15%
withdrawn15%
active_not_recruiting316%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT04266249Phase 2

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Active Not Recruiting
NCT02883062Phase 2

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

Active Not Recruiting
NCT06704659Not Applicable

Study on Recurrent Breast Cancer and Repeated Radiation Therapy

Recruiting
NCT01796197Phase 2

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Completed
NCT06378294

Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)

Active Not Recruiting
NCT06425874

The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery

Recruiting
NCT04677075

New Formula to Predict the Need for Reconstructive Coverage Following Mastectomy

Completed
NCT06130111

Spatial Location of Breast Cancer Local Recurrence After Mastectomy

Unknown
NCT06103032

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

Completed
NCT05126667

Analysis of Breast-Conserving Surgery Plus Whole-Breast Irradiation Versus Mastectomy

Completed
NCT03514654Not Applicable

MIAMI Safe Surgery for Multiple Breast Cancers

Completed
NCT04729647Not Applicable

Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer

Completed
NCT02574546

Markers for Predicting Risk of Breast Cancer in Women of Different Races

Withdrawn
NCT03762642

Trends of Mastectomy and Breast-Conserving Surgery in Female Breast Cancer Patients

Completed
NCT02673268Phase 2

Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction

Unknown
NCT00603408Phase 2

Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer

Terminated
NCT02464774Not Applicable

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Unknown
NCT02130739

Horner's SD After Thoracic Epidural Block

Completed
NCT00641628

Nipple Areola Complex Conservation

Completed

All 19 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
19